rs759709172
Variant names: 
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001036.6(RYR3):c.13569C>T(p.Thr4523Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000033   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000040   (  0   hom.  ) 
Consequence
 RYR3
NM_001036.6 synonymous
NM_001036.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -3.19  
Publications
0 publications found 
Genes affected
 RYR3  (HGNC:10485):  (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011] 
RYR3 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
- congenital myopathyInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58). 
BP6
Variant 15-33848362-C-T is Benign according to our data. Variant chr15-33848362-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 461865.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-3.19 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000329  AC: 5AN: 152162Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
5
AN: 
152162
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000137  AC: 34AN: 248886 AF XY:  0.000163   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
34
AN: 
248886
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000397  AC: 58AN: 1461438Hom.:  0  Cov.: 31 AF XY:  0.0000454  AC XY: 33AN XY: 726988 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
58
AN: 
1461438
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
33
AN XY: 
726988
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
33466
American (AMR) 
 AF: 
AC: 
0
AN: 
44710
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
6
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86248
European-Finnish (FIN) 
 AF: 
AC: 
3
AN: 
53356
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5630
European-Non Finnish (NFE) 
 AF: 
AC: 
37
AN: 
1111850
Other (OTH) 
 AF: 
AC: 
10
AN: 
60344
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.456 
Heterozygous variant carriers
 0 
 3 
 6 
 10 
 13 
 16 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000329  AC: 5AN: 152162Hom.:  0  Cov.: 32 AF XY:  0.0000673  AC XY: 5AN XY: 74324 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
5
AN: 
152162
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
5
AN XY: 
74324
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41442
American (AMR) 
 AF: 
AC: 
0
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
3
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68028
Other (OTH) 
 AF: 
AC: 
0
AN: 
2086
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.515 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Epileptic encephalopathy    Benign:1 
Dec 03, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.